Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
As of close of business last night, Denali Therapeutics Inc’s stock clocked out at $21.59, down -2.88% from its previous closing price of $22.23. In other words, the price has decreased by -$2.88 from its previous closing price. On the day, 0.78 million shares were traded.
Ratios:
To gain a deeper understanding of DNLI’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.98 and its Current Ratio is at 9.98. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Deutsche Bank on February 11, 2025, initiated with a Buy rating and assigned the stock a target price of $31.
On January 07, 2025, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $31.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jan 06 ’25 when Ho Carole sold 12,255 shares for $20.22 per share. The transaction valued at 247,796 led to the insider holds 178,580 shares of the business.
Ho Carole sold 2,907 shares of DNLI for $60,495 on Jan 07 ’25. The Chief Medical Officer now owns 175,673 shares after completing the transaction at $20.81 per share. On Jan 06 ’25, another insider, Schuth Alexander O., who serves as the COFO and Secretary of the company, sold 12,255 shares for $20.22 each. As a result, the insider received 247,796 and left with 247,215 shares of the company.
Stock Price History:
Over the past 52 weeks, DNLI has reached a high of $33.33, while it has fallen to a 52-week low of $14.56. The 50-Day Moving Average of the stock is -1.80%, while the 200-Day Moving Average is calculated to be -8.81%.
Shares Statistics:
A total of 143.84M shares are outstanding, with a floating share count of 124.56M. Insiders hold about 13.45% of the company’s shares, while institutions hold 88.86% stake in the company.
